Solid Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Solid Biosciences (SLDB).

Price Target Range — 13 Quarters

Analyst Consensus — 17 Analysts

2S.Buy

15Buy

Consensus RatingBuy# Analysts17Avg. Consensus PT$18Upside to Avg. PT+202.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 15, 2026	UBS	Joon Lee	Initiate	Buy	$20
Sep 16, 2026	RBC Capital	Luca Issi	Initiate	Outperform	$18
Sep 14, 2026	HC Wainwright & Co.	Arthur He	Maintained	Buy	$25
Aug 27, 2026	Cantor Fitzgerald	Kristen Kluska	PT Raise	Overweight	$16→$26
Aug 21, 2026	Truist Securities	Danielle Brill	PT Raise	Buy	$16→$20
Jun 3, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$20→$25
May 18, 2026	Wedbush	Laura Chico	Maintained	Outperform	$16
May 13, 2026	Wedbush	Laura Chico	PT Cut	Outperform	$17→$16
May 13, 2026	Piper Sandler	Biren Amin	PT Raise	Overweight	$17→$18
Mar 25, 2026	JP Morgan	Anupam Rama	PT Raise	Overweight	$11→$12
Mar 23, 2026	HC Wainwright & Co.	Arthur He	Maintained	Buy	$20
Mar 20, 2026	Guggenheim	Debjit Chattopadhyay	Initiate	Buy	$26
Mar 20, 2026	Chardan Capital	Geulah Livshits	Maintained	Buy	$15
Mar 20, 2026	Needham	Gil Blum	Maintained	Buy	$19
Mar 12, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$14→$17
Mar 12, 2026	Chardan Capital	Geulah Livshits	Maintained	Buy	$15
Mar 11, 2026	Wedbush	Laura Chico	Maintained	Outperform	$14
Feb 9, 2026	Needham	Gil Blum	Maintained	Buy	$16
Jan 14, 2026	Needham	Gil Blum	Maintained	Buy	$16
Dec 4, 2025	Needham	Gil Blum	Initiate	Buy	$16

Analyst Ratings News

PRO
UBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20

UBS analyst Joon Lee initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy rating and announces Price Target of $20.

Benzinga Newsdesk

This Brinker Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated coverage: Neutral on MCD; Buy on MOVE and EAT; Outperform on SLDB; Equal-Weight on GOLF, with price targets announced.

Avi Kapoor

PRO
RBC Capital Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $18

RBC Capital analyst Luca Issi initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Outperform rating and announces Price Target of $18.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $25 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $25 price target.

Benzinga Newsdesk

Nvidia To Rally Around 146%? Here Are 10 Top Analyst Forecasts For Thursday

Wall Street analysts changed outlook on top names: Evercore raised Salesforce target, Needham raised Nutanix target, Ascendiant raised PAVmed target, Cantor raised Okta target, Piper raised Veeva target, Cantor boosted Solid Biosciences target, BTIG raised Crowdstrike target, Cantor cut Dycom target.

Avi Kapoor

PRO
Cantor Fitzgerald Maintains Overweight on Solid Biosciences, Raises Price Target to $26

Cantor Fitzgerald analyst Kristen Kluska maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $16 to $26.

Benzinga Newsdesk

Solid Biosciences Inc

Solid Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20

This Brinker Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
RBC Capital Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $18

PRO
HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $25 Price Target

Nvidia To Rally Around 146%? Here Are 10 Top Analyst Forecasts For Thursday

PRO
Cantor Fitzgerald Maintains Overweight on Solid Biosciences, Raises Price Target to $26

People Also Watch

People Also Watch

Solid Biosciences Inc

Solid Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20

This Brinker Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRORBC Capital Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $18

PROHC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $25 Price Target

Nvidia To Rally Around 146%? Here Are 10 Top Analyst Forecasts For Thursday

PROCantor Fitzgerald Maintains Overweight on Solid Biosciences, Raises Price Target to $26

People Also Watch

People Also Watch

PRO
UBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20

PRO
RBC Capital Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $18

PRO
HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $25 Price Target

PRO
Cantor Fitzgerald Maintains Overweight on Solid Biosciences, Raises Price Target to $26